These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35372441)

  • 1. The Application Value of Syndecan-2 Gene Methylation for Colorectal Cancer Diagnosis: A Clinical Study and Meta-Analyses.
    Yue C; Zhang Y; Wang Y; Zhang Z; Zhang M; Wang H; Chen W; Shang Z; Xin Y; Zhang X; Zhang Y
    Front Med (Lausanne); 2022; 9():753545. PubMed ID: 35372441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA.
    Ma L; Qin G; Gai F; Jiang Y; Huang Z; Yang H; Yao S; Du S; Cao Y
    BMC Gastroenterol; 2022 Apr; 22(1):191. PubMed ID: 35436855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of quantifying
    Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
    Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
    Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
    Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer.
    Zhang W; Yang C; Wang S; Xiang Z; Dou R; Lin Z; Zheng J; Xiong B
    Cancer Manag Res; 2021; 13():3601-3617. PubMed ID: 33958894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of SDC2 and NDRG4 methylation in stool for colorectal cancer diagnosis.
    Long L; Sun Q; Yang F; Zhou H; Wang Y; Xiao C; He Q; Yi B
    Clin Biochem; 2024 Feb; 124():110717. PubMed ID: 38224931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial.
    Kim CW; Kim H; Kim HR; Kye BH; Kim HJ; Min BS; Oh TJ; An S; Lee SH
    BMC Gastroenterol; 2021 Apr; 21(1):173. PubMed ID: 33858326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined detection of SDC2/ADHFE1/PPP2R5C methylation in stool DNA for colorectal cancer screening.
    Li B; Liu S; Gao Y; Zheng L; Lu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10241-10253. PubMed ID: 37270460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer.
    Song JH; Oh TJ; An S; Lee KH; Kim JY; Kim JS
    World J Gastrointest Surg; 2023 Sep; 15(9):2032-2041. PubMed ID: 37901726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of DNA-based SDC2 methylation test in colorectal cancer screening: a meta-analysis.
    Wang L; Liu Y; Zhang D; Xiong X; Hao T; Zhong L; Zhao Y
    BMC Gastroenterol; 2022 Jun; 22(1):314. PubMed ID: 35754025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2.
    Zhao G; Ma Y; Li H; Li S; Zhu Y; Liu X; Xiong S; Liu Y; Miao J; Fei S; Zheng M; Zhao X
    Clin Chim Acta; 2020 Apr; 503():84-89. PubMed ID: 31962098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of combined detection of multigene mutation and SDC2/SFRP2 methylation in stool specimens for colorectal cancer early diagnosis.
    Lin J; Zhang L; Chen M; Chen J; Wu Y; Wang T; Lu Y; Ba Z; Cheng X; Xu R; Tian T; Sun A; Zhang T; Chen M
    Int J Colorectal Dis; 2022 Jun; 37(6):1231-1238. PubMed ID: 35499710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of
    Park YS; Kim DS; Cho SW; Park JW; Jeon SJ; Moon TJ; Kim SH; Son BK; Oh TJ; An S; Kim JH; Chae JD
    Gut Liver; 2018 Sep; 12(5):508-515. PubMed ID: 29730903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stool DNA Test of Methylated
    Niu F; Wen J; Fu X; Li C; Zhao R; Wu S; Yu H; Liu X; Zhao X; Liu S; Wang X; Wang J; Zou H
    Cancer Epidemiol Biomarkers Prev; 2017 Sep; 26(9):1411-1419. PubMed ID: 28619831
    [No Abstract]   [Full Text] [Related]  

  • 15. Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer.
    Su WC; Kao WY; Chang TK; Tsai HL; Huang CW; Chen YC; Li CC; Hsieh YC; Yeh HJ; Chang CC; Wang JY
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33393623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer.
    Oh T; Kim N; Moon Y; Kim MS; Hoehn BD; Park CH; Kim TS; Kim NK; Chung HC; An S
    J Mol Diagn; 2013 Jul; 15(4):498-507. PubMed ID: 23747112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the clinical performance of
    Zhang K; He Q; Cao Q; Chuan J; Qin A; Tang L; Zhang X; Xiao C; Zhu B; Hu M; Chang L; Bu ZX; Fu L; Yang T; Wang Y; Liu W
    Epigenomics; 2024 Jan; 16(2):93-108. PubMed ID: 38226561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of
    Siri G; Alesaeidi S; Dizghandi SE; Alani B; Mosallaei M; Soosanabadi M
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S354-S358. PubMed ID: 36510988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Stool DNA-Based SDC2 Methylation Test for the Early Detection of Colorectal Cancer in an Asymptomatic, High-Risk Population: A Multicenter Prospective Randomized Trial.
    Kim CW; Kim H; Kim HR; Won DD; Nam WJ; Min BS; Oh TJ; An S; Lee SH
    Am J Gastroenterol; 2024 Aug; ():. PubMed ID: 39292188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of
    Zhang L; Dong L; Lu C; Huang W; Yang C; Wang Q; Wang Q; Lei R; Sun R; Wan K; Li T; Sun F; Gan T; Lin J; Yin L
    Front Mol Biosci; 2021; 8():706754. PubMed ID: 35004840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.